Astrazeneca PLC (AZN)

The momentum for this stock is not very good. Astrazeneca PLC (AZN) is not very popular among insiders. Astrazeneca PLC (AZN) is a mediocre stock to choose.
Log in to see more information.
AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing o...
AZN Fundamental Data by TradingView

News

AstraZeneca (NASDAQ:AZN) Upgraded by Erste Group Bank to "Buy"
AstraZeneca (NASDAQ:AZN) Upgraded by Erste Group Bank to "Buy"

Zolmax Erste Group Bank upgraded shares of AstraZeneca (NASDAQ:AZN - Free Report) from a hold rating to a buy rating in a research note published on Wednesday morning, Benzinga reports.\nA number of other...\n more…

BioInvent Announces the Enrollment of the First Patient in Triple Combination Arm of BI-1206, Rituximab and Calquence(R) for the Treatment of non-Hodgkin's Lymphoma
BioInvent Announces the Enrollment of the First Patient in Triple Combination Arm of BI-1206, Rituximab and Calquence(R) for the Treatment of non-Hodgkin's Lymphoma

Accesswire First patient enrolled in Phase 2a study arm combining BI-1206 with rituximab and acalabrutinibwith initial data expected YE 2024Clinical supply agreement for acalabrutinib with AstraZeneca in...\n more…

Kepler Capital Sticks to Their Hold Rating for AstraZeneca (AZN)
Kepler Capital Sticks to Their Hold Rating for AstraZeneca (AZN)

TipRanks Financial Blog In a report released on September 10, David Evans from Kepler Capital maintained a Hold rating on AstraZeneca (AZN - Research Report), with a price...\n more…

Dorsey & Whitney Trust CO LLC Purchases 387 Shares of AstraZeneca PLC (NASDAQ:AZN)
Dorsey & Whitney Trust CO LLC Purchases 387 Shares of AstraZeneca PLC (NASDAQ:AZN)

Zolmax Dorsey Whitney Trust CO LLC lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 1.9% during the 2nd quarter, according to its most recent disclosure with the...\n more…

Erste upgrades AstraZeneca to Buy on strong oncology sales growth
Erste upgrades AstraZeneca to Buy on strong oncology sales growth

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Private Advisor Group LLC Grows Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)
Private Advisor Group LLC Grows Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)

Ticker Report Private Advisor Group LLC grew its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 7.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange...\n more…